Kimia Bioscien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
32.35
0.55 (1.73%)
BSENSE

Jun 18

BSE+NSE Vol: 1.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.35",
    "chg": 0.55,
    "chgp": "1.73%",
    "dir": 1,
    "prev_price": "31.80",
    "mcapval": "153.06 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE285U01025",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.59 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-sell-3989177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/KimiaBioscience_mojoScore_3989177.png",
        "date": "2026-05-13 10:11:11",
        "description": "Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-sell-3955708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3955708.png",
        "date": "2026-04-21 10:10:52",
        "description": "Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Ltd Upgraded to Sell on Technical Improvement Despite Lingering Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-upgraded-to-sell-on-technical-improvement-despite-lingering-fundamental-concerns-3940986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3940986.png",
        "date": "2026-04-10 08:03:46",
        "description": "Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026, driven primarily by improvements in its technical outlook despite ongoing fundamental challenges. This shift reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a cautious but more optimistic stance on the micro-cap pharmaceutical company."
      },
      {
        "title": "Kimia Biosciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-ltd-is-rated-strong-sell-3934084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/KimiaBioscience_mojoScore_3934084.png",
        "date": "2026-04-06 10:10:39",
        "description": "Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kimia Biosciences Falls 13.45%: Downgrade and 52-Week Low Mark a Challenging Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-falls-1345-downgrade-and-52-week-low-mark-a-challenging-week-3922233",
        "imagepath": "",
        "date": "2026-03-28 16:11:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 23:</strong> Downgrade to Strong Sell announced; stock closes at Rs.28.00 (-4.44%)</p>\n                    <p><strong>Mar 24:</strong> Stock rebounds modestly to Rs.28.67 (+2.39%) amid broader market gains</p>\n                    <p><strong>Mar 25:</strong> Slight decline to Rs.28.46 (-0.73%) despite Sensex rally</p>\n                    <p><strong>Mar 27:</strong> Stock plunges to 52-week low of Rs.24, closing at Rs.25.36 (-10.89%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.30</div></div>\n                    <div class=\"stat-item\"><div class=..."
      }
    ],
    "total": 12,
    "sid": "263659",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Publication of Results for quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Held On 29 May 2026",
      "datetime": "29-May-2026",
      "details": "Approval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015",
      "datetime": "20-May-2026",
      "details": "Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

01-Jun-2026 | Source : BSE

Publication of Results for quarter and year ended March 31 2026

Outcome Of The Board Meeting Held On 29 May 2026

29-May-2026 | Source : BSE

Approval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015

20-May-2026 | Source : BSE

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available